Skip to main content

Table 1 Demographic and clinical characteristics of study participants (n = 100)

From: Does Xpert® MTB/RIF assay give rifampicin resistance results without identified mutation? Review of cases from Addis Ababa, Ethiopia

Characteristics

Number

Proportion

Age group

  < 14

5

5%

 15–24

29

29%

 25–34

35

35%

 35–44

17

17%

 45–54

6

6%

 55–64

4

4%

  > 64

2

2%

 Missed

2

2%

 Total

100

100%

Sex

 Male

55

55%

 Female

45

45%

 Total

100

100%

Treatment history

 New

50

55.6%

 Relapse

29

32.2%

 Failure

7

7.8%

 A loss to follow up

4

4.4%

 Total

90

100.0%

Specimen type

 Sputum

62

62.0%

 Extrapulmonary

38

38.0%

 Total

100

100.0%

Extrapulmonary samples

 Lymph node

19

50.0%

 Pleural fluid

5

13.2%

 Pus

4

10.5%

 Abscess

4

10.5%

 Ascetic fluid

3

8.0%

 Unspecified body fluid

2

5.2%

 BAL

1

2.6%

 Total

38

100.0%